BrightAccountsProduction v1.0.0 v1.0.0 2023-01-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts FRS 105 Accounts The principal activity of the company is the provision of private cataract surgery. 30 July 2024 0 0 NI657738 2023-12-31 NI657738 2022-12-31 NI657738 2021-12-31 NI657738 2023-01-01 2023-12-31 NI657738 2022-01-01 2022-12-31 NI657738 uk-bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 NI657738 uk-curr:PoundSterling 2023-01-01 2023-12-31 NI657738 uk-bus:AbridgedAccounts 2023-01-01 2023-12-31 NI657738 uk-core:CapitalReserve 2023-12-31 NI657738 uk-core:CapitalReserve 2022-12-31 NI657738 2023-01-01 2023-12-31 NI657738 uk-bus:Director1 2023-01-01 2023-12-31 NI657738 uk-bus:Director2 2023-01-01 2023-12-31 NI657738 uk-bus:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 NI657738 uk-bus:Micro-entities 2023-01-01 2023-12-31 xbrli:pure iso4217:GBP xbrli:shares
Company Registration Number: NI657738
 
 
Solasta Healthcare Limited
 
Unaudited Financial Statements
 
for the financial year ended 31 December 2023
Solasta Healthcare Limited
Company Registration Number: NI657738
STATEMENT OF FINANCIAL POSITION
as at 31 December 2023

    2023   2022
  £   £
 
Fixed Assets 688   503
  ─────────   ─────────
Current assets 273,600   282,849
Prepayments and accrued income 2,540   -
Creditors: amounts falling due within one year (56,968)   (7,376)
  ─────────   ─────────
Net Current Assets 219,172   275,473
  ─────────   ─────────
Total Assets less Current Liabilities 219,860   275,976
Creditors: amounts falling due after more than one year (319,940)   (319,940)
Accruals and deferred income (660)   (528)
  ─────────   ─────────
Net Liabilities (100,740)   (44,492)
  ═════════   ═════════
 
Capital and Reserves (100,740)   (44,492)
  ═════════   ═════════
 
Notes to the Financial statements
   
1. General Information
 
Solasta Healthcare Limited is a company limited by shares incorporated in Northern Ireland. The registered office of the company is 30a Gortin Road, Omagh, Co Tyrone, BT79 7HX. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
   
2. Going concern
 
The directors have confirmed that they will continue to give financial support to the company until such time as its position improves. In addition the directors have confirmed that they will not recall any loans within 12 months. The directors consider that it is appropriate to prepare the financial statements on a going concern basis. The financial statements do not include any adjustments that would result if the financial support were withdrawn.
       
3. Employees
 
The average monthly number of employees, including directors, during the financial year was 0, (2022 - 0).
   
4. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial year-end.
     
For the financial year ended 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
 
The directors confirm that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
 
The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
 
These financial statements have been prepared in accordance with the provisions available to micro-entities in Part 15 of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
 
The company has taken advantage of the exemption under section 444 not to file the Income Statement.
 
Approved by the Board on 30 July 2024 and signed on its behalf by:
 
 
   
________________________________ ________________________________
Dermot Carlin Frederick John Topping
Director Director